(Fighting New Coronary Pneumonia) Germany has vaccinated 1 million people
China News Agency, Berlin, January 17 (Reporter Peng Dawei) According to data released by the German disease control agency on the 17th, since the start of the new crown vaccination on December 27 last year, Germany has vaccinated more than 1 million people.
However, due to technical reasons, Pfizer and BioNTech temporarily reduced the supply of their new crown vaccine to the European Union, which hindered the progress of vaccination in Germany. At present, Saxony has suspended accepting vaccination appointments.
On January 5, the cumulative number of people diagnosed with the new crown virus in Germany exceeded 1.8 million.
The picture shows a notice posted on the window of a closed flower shop in Berlin, "City closed due to the second round of lockdown."
Photo by China News Agency reporter Peng Dawei
The latest data released by the German disease control agency on the 17th showed that as of 11 am (local time) that day, 1,048,160 people in Germany had received the first dose of the vaccine, accounting for about 1.3% of the total; of these, 79,759 were vaccinated on the 16th. .
The number of newly diagnosed new coronaviruses and deaths on that day were 13,882 and 445 respectively.
According to real-time data from Germany's "Times Online", as of 21:42 that day, Germany had a total of 2,204,405 confirmed diagnoses, 1,671,785 cured, and 47,392 deaths.
Currently, Germany uses two vaccines that have been approved by the European Union. They are the mRNA (messenger ribonucleic acid) vaccine jointly developed by Pfizer and BioNTech of Germany and the mRNA vaccine of Modena.
Among them, most of the vaccines currently distributed to various states are Pfizer-BioNTech vaccines.
On the 15th of this month, Pfizer and BioNTech announced that due to their plans to expand vaccine production capacity in Europe, they will adjust their production processes.
Affected by this, the plant in Pierce, Belgium will temporarily reduce production in the next few weeks.
The two companies stated that they will resume the normal supply of vaccines to the European Union on January 25, and gradually increase the supply from February 15 until the second quarter will substantially increase the supply.
The German Federal Ministry of Health subsequently expressed regret over the news, stating that the health ministers of the Federation and the states "learned about this unexpected news very late."
The Ministry emphasized that this puts forward higher requirements for relevant companies to comply with the agreement signed by it to ensure the supply of sufficient vaccines by mid-February.
Affected by this, the eastern German state of Saxony announced on the 17th that it would no longer accept new vaccination appointments. According to a report by the German Broadcasting Corporation citing the head of the German Red Cross in the state, this is due to "how many doses of vaccine can you arrange for appointments." Currently, the state can only wait for developments. (Finish)